IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse
- PMID: 34996836
- DOI: 10.4049/jimmunol.2100781
IgM to IgG Class Switching Is a Necessary Step for Pemphigus Phenotype Induction in Desmoglein 3-Specific B Cell Receptor Knock-in Mouse
Abstract
Pemphigus vulgaris is an autoimmune blistering disease caused by IgG targeting desmoglein 3 (Dsg3), an adhesion molecule of keratinocytes. Anti-Dsg3 IgG production is prevented in healthy individuals, but it is unclear how Dsg3-specific B cells are regulated. To clarify the immunological condition regulating Dsg3-specific B cells, a pathogenic anti-Dsg3 Ig (AK23) knock-in mouse was generated. AK23 knock-in B cells developed normally without undergoing deletion or acquiring an anergic phenotype in vivo. The knock-in B cells showed Ca2+ influx upon IgM cross-linking and differentiated into AK23-IgG+ B cells after LPS and IL-4 stimulation in vitro that induced a pemphigus phenotype after adoptive transfer into Rag2 -/- mice. However, the knock-in mouse itself produced AK23-IgM but little IgG without blisters in vivo. Dsg3 immunization and skin inflammation caused AK23-IgG production and a pemphigus phenotype in vivo. Furthermore, Fcgr2b deficiency or haploinsufficiency spontaneously induced AK23-IgG production and a pemphigus phenotype with poor survival rates in AK23 knock-in mice. To assess Fcgr2b involvement in Ig class-switch efficiency, postswitch transcripts of B cells were quantified and significantly higher in Fcgr2b -/- and Fcgr2b +/- mice than wild-type mice in a gene dose-dependent manner. Finally, RNA sequencing revealed reduced expression of FCGR2B and FcγRIIB-related genes in patient B cells. These results indicated that Dsg3-specific B cells do not spontaneously perform pathogenic class switching in vivo, and pemphigus phenotype induction was prevented under normal conditions. Attenuated FcγRIIB signaling is also one of the drivers for pathogenic class switching and is consistent with immunological features identified from clinical samples. This study unveiled a characteristic immune state silencing autoreactive B cells in mice.
Copyright © 2022 by The American Association of Immunologists, Inc.
Similar articles
-
Autoreactive B-cell elimination by pathogenic IgG specific for the same antigen: implications for peripheral tolerance.Int Immunol. 2008 Oct;20(10):1351-60. doi: 10.1093/intimm/dxn095. Epub 2008 Sep 2. Int Immunol. 2008. PMID: 18765425
-
Pathogenic relevance of IgG and IgM antibodies against desmoglein 3 in blister formation in pemphigus vulgaris.Am J Pathol. 2011 Aug;179(2):795-806. doi: 10.1016/j.ajpath.2011.04.015. Epub 2011 Jun 12. Am J Pathol. 2011. PMID: 21718682 Free PMC article.
-
A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris.J Immunol. 2009 Feb 1;182(3):1740-5. doi: 10.4049/jimmunol.182.3.1740. J Immunol. 2009. PMID: 19155523
-
Pemphigus vulgaris and its active disease mouse model.Curr Dir Autoimmun. 2008;10:167-81. doi: 10.1159/000131453. Curr Dir Autoimmun. 2008. PMID: 18460885 Review.
-
Desmoglein 3, its pathogenecity and a possibility for therapeutic target in pemphigus vulgaris.Expert Opin Ther Targets. 2013 Mar;17(3):293-306. doi: 10.1517/14728222.2013.744823. Epub 2013 Jan 8. Expert Opin Ther Targets. 2013. PMID: 23294403 Review.
Cited by
-
Immunostimulatory effects of Toll-like receptor ligands as adjuvants in establishing a novel mouse model for pemphigus vulgaris.Clin Transl Med. 2024 Jul;14(7):e1765. doi: 10.1002/ctm2.1765. Clin Transl Med. 2024. PMID: 39031979 Free PMC article.
-
In Vitro, Ex Vivo, and In Vivo Models for the Study of Pemphigus.Int J Mol Sci. 2022 Jun 24;23(13):7044. doi: 10.3390/ijms23137044. Int J Mol Sci. 2022. PMID: 35806044 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous